What Makes GLP-1 Different
Investors were most encouraged by the performance of the lower 4 mg dose of retatrutide, which produced roughly 19 per cent weight loss, comparable to the highest dose of current blockbuster therapy Zepbound
This product is NOT intended for human or veterinary use, is NOT a drug or dietary supplement, and has NOT been evaluated or approved by the FDA or any other regulatory authority for therapeutic, diagnostic, or prophylactic use
11:55 Market Reaction and Strategic Implications Discussion of stock movement, competitive signaling, and how Novos pricing move may blunt Lillys trial victory
Like GIP, GLP-1 is released in response to ingestion of nutrients and acts on pancreatic cells to stimulate insulin secretion
Participants with confirmed liver disease showed substantial reductions in liver fat content and, importantly, improvements in liver inflammation and fibrosis markers